Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma Read more
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis Read more
FDA Grants Priority Review to Amgen’s Tarlatamab Application for Advanced Small Cell Lung Cancer Read more
Abbisko Therapeutics Announces that FDA Has Granted Fast Track Designation for Its CSF-1R Inhibitor Pimicotinib (ABSK021) Read more
Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology Read more
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data Read more
Depixus Announces Strategic Collaboration With Daiichi Sankyo To Use MAGNA Technology To Accelerate RNA-Targeted Drug Discovery Read more